H
HeyPsych
PsychTrails™TreatmentsConditionsResourcesFor CliniciansAbout

Stay updated on mental health treatments

Get the latest research, treatment updates, and evidence-based insights delivered to your inbox. No spam, just valuable mental health information.

Coming Soon

Newsletter subscription will be available soon.

H
HeyPsych

Evidence-based mental health treatment education platform. Helping you make informed decisions about your mental health journey.

Treatments

  • Medications
  • Interventional
  • Investigational
  • Alternative
  • Therapy
  • Supplements

Conditions

  • Depression
  • Anxiety
  • ADHD
  • Bipolar
  • All Conditions

Resources

  • Assessments & Screeners
  • Support & Community
  • Digital Tools
  • Knowledge Hub
  • PsychTrails™

Company

  • About Us
  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 HeyPsych (PsychTrails™). All rights reserved.

Made with for better mental health
v2.2.0

Eszopiclone (Lunesta)

FDA Approved 2004

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published January 22, 2026•Updated January 22, 2026•Reviewed January 22, 2026

Clinical summary for Eszopiclone (Lunesta): Lunesta is a sleep med you take right before bed to help you fall asleep and stay asleep. It’s in the ‘Z-drug’ family, not a classic benzo, but it still acts on the same sleep receptors. Many people sleep better, but there are tradeoffs: bad taste, grogginess the next day, balance problems, and weird sleep behaviors like sleep-walking or even sleep-driving in rare cases. If anything strange like that happens, it needs to be stopped immediately. This is a tool, not a permanent fix, and works best when paired with therapy for insomnia.

What It's Used For

Eszopiclone (Lunesta) is a bedtime hypnotic used to help adults fall asleep and stay asleep when insomnia is causing daytime problems and non-drug options haven’t been enough.

Primary Indications

Insomnia – sleep onset: Difficulty falling asleep at the start of the night despite having time and opportunity to sleep.Insomnia – sleep maintenance: Waking up multiple times per night or waking too early and having trouble falling back asleep.Short-term insomnia: Used when stress, schedule changes, or acute illness temporarily disrupt sleep, with a plan to step back once stability returns.Adjunct to insomnia therapy: Sometimes used as a bridge while cognitive behavioral therapy for insomnia (CBT-I) and behavioral changes are being implemented.

Off-Label Uses

Not applicable for this medication.

What People Feel

People often describe Lunesta as ‘strong but not as heavy as a benzo’—though the line can blur, especially at higher doses or in sensitive brains.

Falling Asleep

"When I take it and then get into bed, my brain finally stops replaying the day and I drift off."

How Fast It Works

Eszopiclone is a fast-onset hypnotic: you take it when you’re ready to shut things down, not while you’re still doing chores or answering emails.

Rapid onset

Typically starts working within about 30–60 minutes when taken immediately before bedtime.

Peak effect

Blood levels peak around 1 hour after ingestion, aligning with early sleep stages.

Half-life

Around 6 hours in healthy adults and about 9 hours in older adults, which explains why next-day effects can show up, especially at higher doses.

Duration of action

Designed to cover the night for both falling asleep and staying asleep; effects may spill into the morning if you don’t get a full 7–8 hours in bed.

Food effect

A heavy or high-fat meal can delay onset, leaving you awake longer and raising the odds of next-day grogginess.

How Well It Works

Sleep latency and total sleep time

Meaningful but modest improvements on average
vs Improves sleep more than placebo, but benefits in latency and total sleep time are generally small to moderate and can be similar to other ‘Z-drugs’ and benzodiazepine hypnotics.
Eszopiclone can shave down the time it takes to fall asleep and reduce the number of awakenings, especially in the first weeks of use. For some people, that’s enough to feel like a real win. For others, the tradeoff—grogginess, odd taste, or safety concerns—can outweigh the benefit. And no pill can compete long term with CBT-I when it comes to durable insomnia recovery.

Critical Safety Information

Critical Safety Information

Eszopiclone carries an FDA boxed warning for complex sleep behaviors like sleep-walking and sleep-driving, which can lead to serious injury or death. If these occur, the medication must be stopped immediately.
  • →Take Lunesta only when you can stay in bed for a full 7–8 hours. If you have to wake up early, skip it.
  • →If anyone tells you that you’ve done strange things in your sleep—walking, eating, driving, making calls—or you find evidence of activities you don’t remember, stop the medication and contact your prescriber immediately.
  • →Do not mix Lunesta with alcohol or other sedative medications unless your prescriber has explicitly reviewed the combination. The risk of accidents and complicated behaviors goes way up.
  • →If your sleep is not improving after 7–10 days, or your mood is worsening, we need to reassess the diagnosis and treatment—not just keep increasing the dose.
  • →Don’t stop suddenly if you’ve been taking it regularly, especially at higher doses. We want a slow, planned taper to reduce rebound insomnia and withdrawal.
  • →This medication is a bridge, not the destination. Pair it with CBT-I or other behavioral sleep strategies so you’re not reliant on a pill long term.

Side Effects

Most people notice bad taste, headache, and some degree of sedation; the big red flags are complex sleep behaviors, next-day impairment, mood changes, and rare allergic reactions.

Common Things People Notice

  • Bitter or metallic taste in the mouth (very common)
  • Headache
  • Drowsiness and next-day grogginess
  • Dizziness or feeling off-balance
  • Weird or vivid dreams, sometimes nightmares
  • Anxiety, mood changes, or worsening depression
  • Rare but serious complex sleep behaviors (doing things while not fully awake, with no memory afterward)

Common Side Effects

≈15–21%
Headache— Headaches can show up the morning after or later in the day. They’re usually mild to moderate, but if they’re severe, persistent, or associated with other neurological symptoms, let your prescriber know.
≈8–34%
Dysgeusia (Bad or Metallic Taste)— This is one of Lunesta’s signature side effects. People describe a strong bitter or metallic taste that can linger into the next day. Sips of water may help, but often it’s just something you have to weigh against the sleep benefits.
Drowsiness ≈8–10%; dizziness ≈5–7%
Drowsiness and Dizziness— Feeling sleepy is the point, but if you’re still groggy the next day or feel woozy when you stand up, we may need to lower the dose or rethink the medication—especially if you drive or do safety-sensitive work.
Dry mouth ≈3–7%; nausea ≈4–5%; dyspepsia and diarrhea ≈2–6%
GI Symptoms (Dry Mouth, Nausea, Dyspepsia, Diarrhea)— Mild stomach upset, dry mouth, or loose stools are pretty common. Hydration, lighter evening meals, and timing of the dose can help, but if GI issues are intense or persistent, bring it up.
Depression 1–4%; anxiety 1–3%; confusion ≤3%; hallucinations 1–3%; abnormal dreams 1–3%
Mood and Cognitive Changes— This is where we get cautious. If your mood worsens, you feel more anxious, you see or hear things that aren’t there, or your behavior feels out of character, we need to know immediately.
Rash 3–4%; pruritus 1–4%
Skin Reactions and Itching— Mild rashes or itchiness can happen with many medications. However, any severe, blistering, or spreading rash—especially with fever or facial swelling—needs urgent attention.

⚠️ Serious Side Effects

  • Complex sleep behaviors (sleep-walking, sleep-driving, sleep-eating, having sex while not fully awake) with no memory afterward. These can cause serious injuries, legal issues, or death and require immediate discontinuation.
  • Severe allergic reactions: Anaphylaxis and angioedema (swelling of tongue, throat, or face) can occur, sometimes after the first dose. This is an emergency.
  • Severe psychiatric reactions: Agitation, aggression, hallucinations, suicidal ideation, or drastic behavior changes may occur and need urgent reassessment.
  • Respiratory compromise: Sedation can worsen underlying sleep apnea or COPD and lead to breathing problems during sleep.
  • Severe withdrawal: After high-dose or prolonged use, abrupt discontinuation may cause seizures, delirium, disorientation, hypertension, severe anxiety, or tremor—these require urgent medical care.
  • Serious dermatologic reactions: Rare, but erythema multiforme and other serious rashes have been reported.

Critical Drug Interactions

Eszopiclone is a CNS depressant and a CYP3A4 substrate. The main interaction themes: more sedation, more next-day impairment, and higher blood levels with CYP3A4 inhibitors.

With: Alcohol

Risk: Additive CNS depression, increased risk of complex sleep behaviors, blackouts, and impaired judgment.

Action: Do not combine. Avoid alcohol completely when taking eszopiclone, especially near bedtime.

With: Other CNS Depressants (benzodiazepines, Z-drugs, opioids, barbiturates, sedating antihistamines, antipsychotics, gabapentinoids)

Risk: Increased sedation, respiratory depression, complex sleep behaviors, and next-day psychomotor impairment.

Action: Avoid stacking sedatives. If unavoidable, use the lowest effective doses, adjust eszopiclone dose downward, and monitor closely for oversedation and unusual behaviors.

With: Strong CYP3A4 Inhibitors (eg, ketoconazole, itraconazole, certain HIV protease inhibitors, some macrolide antibiotics)

Risk: Increased eszopiclone levels and prolonged sedation, raising risk of next-day impairment and complex behaviors.

Action: Avoid high doses of eszopiclone in combination; consider limiting to 1 mg, or using an alternative hypnotic not dependent on CYP3A4. Monitor for excessive sedation.

With: CYP3A4 Inducers (eg, rifampin, some anticonvulsants)

Risk: Decreased eszopiclone levels and reduced hypnotic effect, potentially driving dose escalation.

Action: Avoid if possible. If used together, focus on nonpharmacologic insomnia treatment rather than escalating eszopiclone doses.

With: Other Sedative-Hypnotics at Bedtime

Risk: Markedly increased risk of complex sleep behaviors, profound sedation, and breathing impairment.

Action: Do not use multiple hypnotics (eg, eszopiclone + another ‘sleep med’) at the same bedtime or during the night.

Safe Discontinuation

Eszopiclone isn’t as famous for withdrawal as benzos, but it still hits GABA systems—so a thoughtful taper is far kinder to your brain than a sudden stop.

Key Points

  • General approach: Reduce the dose gradually rather than stopping abruptly, especially after higher doses (eg, 3 mg) or long-term nightly use.
  • Standard taper: Decrease by about 25% of the original dose each week or every other week. Practically, this often means reducing by 1 mg steps (eg, 3 → 2 → 1 → off) over several weeks.
  • High-dose or prolonged use: Go slower. For patients who’ve relied on 3 mg for months or years, tapering over several months with CBT-I support is usually more successful and safer.
  • Rebound insomnia: Expect sleep to get worse temporarily as the dose drops; this doesn’t necessarily mean you ‘need’ the medication, it means your sleep system is recalibrating.
  • Withdrawal symptoms: Can include anxiety, restlessness, agitation, insomnia, tremor, and in rare cases more severe symptoms like delirium or seizures after abrupt discontinuation.
  • Supportive care: Pair tapering with CBT-I, sleep hygiene, and management of underlying mood or anxiety disorders to give sleep something to land on when the medication goes away.

Dosing Information

Adult Dosing

sleep initial: 1 mg PO once nightly immediately before bedtime as needed for insomnia. Take only when you can stay in bed for a full 7–8 hours.

sleep max: Up to 3 mg PO once nightly for adults based on response and tolerability; higher doses increase risk of next-day impairment and complex sleep behaviors.

tapering: When discontinuing, reduce dose by about 25% of the original dose each week or every other week (eg, 3 mg → 2 mg → 1 mg → off). For long-term 3 mg users, consider slower tapers and CBT-I support.

older adult: Avoid if possible. If used, start at 1 mg PO at bedtime and increase cautiously to a maximum of 2 mg nightly, with close monitoring for falls, confusion, and next-day impairment.

hepatic: Mild to moderate impairment: no adjustment usually needed. Severe hepatic impairment: initiate at 1 mg immediately before bedtime, with a maximum of 2 mg nightly due to doubled systemic exposure.

renal: No dosage adjustment is generally necessary in renal impairment; eszopiclone is primarily hepatically metabolized and excreted as metabolites.

administration: Administer immediately before going to bed or after getting into bed and realizing you can’t fall asleep. Do not take with or right after a heavy or high-fat meal.

Simple Explanation

For most adults, Lunesta starts at 1 mg right before bed and can be nudged up to 2 or 3 mg if needed. Older adults usually shouldn’t go above 2 mg, and many shouldn’t take it at all. When it’s time to come off, we step the dose down slowly instead of just yanking it away overnight.

Pregnancy, Breastfeeding, Special Groups

With eszopiclone, we’re always weighing short-term relief from insomnia against longer-term safety for vulnerable bodies and brains.

👶Pregnancy

Eszopiclone is the S-isomer of zopiclone. Data with this class suggest an association with preterm birth, low birth weight, and small-for-gestational-age infants when used chronically in pregnancy, but findings are not uniform and confounded by maternal illness. Long-term hypnotic use is generally discouraged in pregnancy. Nonpharmacologic insomnia treatments (sleep hygiene, CBT-I) are preferred. If eszopiclone is used, employ the lowest effective dose for the shortest possible time, reassess frequently, and plan a gradual discontinuation to reduce rebound insomnia.

🤱Breastfeeding

It is unknown whether eszopiclone itself is present in human milk, but its racemic parent zopiclone is excreted in breast milk. Sedation, poor feeding, and weight changes are theoretical risks in exposed infants. Decisions about breastfeeding while on eszopiclone should weigh maternal sleep and mental health needs against potential infant exposure. If used, choose the lowest effective dose, consider timing doses right after the last feed of the evening, and monitor infants closely for sedation and feeding difficulties.

👧Children & Adolescents (Under 18)

Eszopiclone is not approved for children or adolescents. Data are limited and concerns about misuse, paradoxical reactions, and impact on developing sleep–wake regulation mean nonpharmacologic interventions are strongly preferred.

👴Older Adults (65+)

Older adults are more sensitive to hypnotics and show increased exposure (higher AUC and longer half-life). Eszopiclone is listed in Beers Criteria as potentially inappropriate in adults ≥65 due to risks similar to benzodiazepines (falls, fractures, delirium, motor vehicle accidents) with only modest sleep benefit. If used at all, doses should be very low (usually 1 mg, max 2 mg), duration short, and monitoring tight.

🔬Liver Impairment

In severe hepatic impairment, systemic exposure to eszopiclone is doubled, prompting lower maximum doses (1–2 mg) and careful monitoring for oversedation and cognitive changes. Mild to moderate hepatic impairment generally does not require dose adjustment, but caution remains appropriate.

💧Kidney Impairment

Eszopiclone and its metabolites are largely handled by the liver, with metabolites excreted in urine. Significant dose adjustment is not typically needed in renal impairment, but comorbidities and concomitant drugs in kidney disease still increase risk of falls and sedation.

Clinical Monitoring

  • Daytime alertness and psychomotor performance: Ask about next-day grogginess, driving safety, workplace performance, and near-miss events.
  • Complex sleep behaviors: At each visit, ask the patient and, when possible, bed partners about sleep-walking, sleep-eating, sleep-driving, or other odd nighttime activities with amnesia.
  • Sleep pattern and quality: Track sleep onset, awakenings, early morning waking, and overall satisfaction with sleep. Persistent insomnia warrants re-evaluation of underlying causes.
  • Mood and suicidality: Screen for depression, anxiety, and suicidal ideation, especially if insomnia persists or worsens. Hypnotics can unmask or exacerbate mood disorders.
  • Substance use: Monitor alcohol and sedative use; eszopiclone should not be layered on top of significant alcohol or sedative use.
  • Withdrawal and rebound: During and after tapering, monitor for rebound insomnia, anxiety, autonomic symptoms, and rarely more severe withdrawal phenomena.
  • Falls and cognitive effects: Particularly in older or debilitated patients, watch for falls, confusion, memory issues, or functional decline.
  • Hepatic function: In severe hepatic impairment, consider periodic liver function tests and clinical monitoring for exaggerated sedation or prolonged effects.
  • Concomitant medications: Regularly review for interacting CNS depressants and CYP3A4 inhibitors or inducers that may alter eszopiclone exposure.

Available Formulations

  • US Oral Tablets (Lunesta brand): 1 mg, 2 mg, 3 mg.
  • US Generic Oral Tablets: 1 mg, 2 mg, 3 mg; multiple manufacturers, often lower cost than brand.
  • Canada Oral Tablets (Lunesta and generics): 1 mg, 2 mg, 3 mg.
  • Coloring: Some strengths contain FD&C Blue #2; relevant for patients with dye sensitivities.
  • Administration: Take immediately before bedtime; do not take with or immediately after a heavy or high-fat meal to avoid delayed onset and increased next-day impairment.

Mechanism of Action

Eszopiclone is a nonbenzodiazepine hypnotic that still acts on benzodiazepine receptor sites. It binds to GABA-A receptor complexes at or near the benzodiazepine binding site, enhancing the inhibitory effects of GABA. That increased chloride flow hyperpolarizes neurons, making them less excitable and dialing down arousal circuits that keep you awake. It is structurally distinct from benzodiazepines but functionally similar at the receptor level, which is why its side effect and dependence profile overlaps with traditional benzos.

Place in Treatment Algorithm

Eszopiclone sits in the ‘Z-drug’ bucket—often marketed as a cleaner alternative to benzodiazepines, but in older adults and in real-world use it behaves more like a cousin than a distant relative. For chronic insomnia, first-line treatment remains CBT-I and behavioral strategies (stimulus control, sleep restriction, circadian work). When a hypnotic is needed, short-term use of a Z-drug like eszopiclone can make sense, especially when sleep maintenance is a major issue. It should not be first-line for people with untreated depression, substance use disorders, or high fall risk. The goal is usually: (1) use the smallest effective dose, (2) keep duration as short as practical, (3) treat the underlying drivers of insomnia, and (4) plan from the beginning how you’ll taper off rather than waiting until years have passed and dependence is entrenched.

Frequently Asked Questions

What is Lunesta (eszopiclone) used for?

Lunesta is a prescription sleep medication used to treat insomnia in adults. It helps with both sleep onset (falling asleep) and sleep maintenance (staying asleep through the night). It’s not an antidepressant or daytime anxiety medication and should only be taken right before bedtime.

How should I take eszopiclone for insomnia?

Take eszopiclone by mouth immediately before bedtime, when you are ready to turn off the lights and go to sleep. The usual starting dose is 1 mg at bedtime, and your prescriber may increase it to 2 or 3 mg if needed. Only take it when you can stay in bed for at least 7–8 hours. Don’t take it after a heavy or high-fat meal, because that delays onset and increases next-day grogginess.

What are complex sleep behaviors and why is there a boxed warning?

Complex sleep behaviors are things you do while not fully awake that you don’t remember afterward, like sleep-walking, sleep-driving, cooking and eating, making phone calls, or even having sex. With eszopiclone and other Z-drugs, these behaviors have led to car crashes, injuries, and deaths, even at normal doses and without alcohol. If you or someone else notices any of these behaviors, Lunesta should be stopped immediately and not restarted.

Will Lunesta make me feel hung over the next day?

It can. At higher doses (2–3 mg), in older adults, or if you don’t get a full night of sleep, you may feel groggy, slow, or off-balance the next day. Your reaction time and concentration may be impaired even if you feel ‘okay.’ That’s why we usually start at 1 mg, push for a full 7–8 hours in bed, and avoid use in older adults when possible.

Can I drive the day after taking eszopiclone?

If taken correctly—at an appropriate dose, with a full 7–8 hours in bed, and without other sedatives—many people can drive the next day. But some will still be impaired, especially on 3 mg. If you feel groggy, dizzy, or mentally slowed, don’t drive. If you have a safety-sensitive job (driving, operating machinery, healthcare, law enforcement), talk with your prescriber about whether Lunesta is appropriate at all.

Is eszopiclone safer than a benzodiazepine for sleep?

It’s marketed as a ‘non-benzodiazepine’ hypnotic, but functionally it still acts on the same GABA-A benzodiazepine receptor complex. In older adults, its risk profile—falls, fractures, delirium, motor vehicle accidents—looks more similar to benzos than different. It can still cause dependence, withdrawal, complex sleep behaviors, and next-day impairment. So we treat it with similar respect and caution.

Can Lunesta be addictive?

Yes. While dependence and misuse risk may be somewhat lower than with some benzodiazepines, eszopiclone still hits the GABA system and can lead to psychological and physical dependence, especially with nightly long-term use. People may feel they cannot sleep without it, and stopping suddenly can cause rebound insomnia and withdrawal symptoms. That’s why we use the lowest effective dose, shortest duration, and plan a taper.

What happens if I stop eszopiclone suddenly?

If you’ve only used it occasionally for a short time, you may be fine or have a night or two of rougher sleep. If you’ve used it nightly or at higher doses for longer periods, stopping abruptly can cause rebound insomnia, anxiety, restlessness, and sometimes more severe symptoms like confusion, elevated blood pressure, or seizures. It’s much safer to taper down gradually with your prescriber’s guidance.

Is Lunesta safe in older adults?

In adults 65 and older, eszopiclone and other Z-drugs are generally considered potentially inappropriate because the benefit in sleep is small and the risk of falls, fractures, confusion, and car crashes is higher. If used at all, doses should be very low, duration short, and monitoring close—but in many cases, safer alternatives and CBT-I are a better path.

Can I take Lunesta if I have depression or anxiety?

You can, but with caution. Lunesta does not treat depression or anxiety, and in some people hypnotics can worsen mood or unmask suicidal thoughts. If you have depression or anxiety, those conditions should be treated directly with therapy, antidepressants, or other appropriate strategies. Any new or worsening mood symptoms on Lunesta should prompt a quick check-in with your prescriber.

What about Lunesta in pregnancy or while breastfeeding?

We don’t have great data for eszopiclone specifically, but related drugs and class data suggest possible risks like preterm birth and low birth weight with long-term use in pregnancy. Zopiclone (its racemic parent) does pass into breast milk. Generally, we avoid chronic Z-drug use in pregnancy and breastfeeding and instead lean hard on non-drug sleep strategies. If insomnia is so severe that medication is being considered, the decision should be made together with your prescriber, considering your mental health, pregnancy risks, and other options.

How does Lunesta fit into a long-term plan for insomnia?

Ideally, Lunesta is a short-term tool while you work on long-term fixes: CBT-I, circadian rhythm alignment, consistent wake times, managing caffeine, addressing pain or mood issues, and so on. We use it to buy you some sleep while you build skills and routines. Once those are in place and working, we slowly taper the medication and see how your sleep holds up without it. If the pill is doing all the work and nothing else has changed, we’ve missed the real treatment opportunity.

This medication information is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Never take medication without a prescription from a licensed healthcare provider.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists